‘Experimental design’: these words signal a section of a research paper that many readers might be inclined to scan fleetingly, before moving on to the actual findings. But a study in Nature this week ...

Invivyd (IVVD) announced that the SPEAR Study Group has issued their consensus recommendation for a clinical study design to evaluate the effects of monoclonal antibody, mAb, therapy on Long COVID.